Literature DB >> 26449788

Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis.

Magdalena Meszaros1, Georges-Philippe Pageaux2, Romain Altwegg2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26449788     DOI： 10.1093/ecco-jcc/jjv182

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  2 in total

1.  Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.

Authors:  Saqib Mumtaz; Jason Goh; Gideon M Hirschfield; James Ferguson; Sheldon C Cooper
Journal:  Frontline Gastroenterol       Date:  2016-08-05

2.  Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.

Authors:  Mohamad A Mouchli; Siddharth Singh; Lisa Boardman; David H Bruining; Amy L Lightner; Charles B Rosen; Julie K Heimbach; Bashar Hasan; John J Poterucha; Kymberly D Watt; Sunanda V Kane; Laura E Raffals; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.